Historical record - last NADAC effective date: 5/22/2024
Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Lifestar Pharma LLC, priced at $0.5258 per ML under NDC 70756061825. Its NADAC has been published 29 times since Apr 17, 2024.
FDA first approved this application on Dec 16, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Lifestar Pharma LLCNDC
70756061825
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
5/22/2024
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216860FDA Approved
12/16/2022
TE Code
AP
On Market Since
12/17/2022
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 29 times since Apr 17, 2024, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5258 per ML |
|---|---|
| All-time high | $0.6277 (May 15, 2024) |
| All-time low | $0.5258 (May 22, 2024) |
| Median price | $0.5258 |
| Average price | $0.5434 |
| Largest weekly change | -16.2% (May 22, 2024) |
| Weeks tracked | 29 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-16.2%
Last surveyed Oct 30, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Lifestar Pharma LLC, is $0.5258 per ML (NDC 70756061825), effective Oct 30, 2024.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has declined 16.2%. It has been tracked across 29 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Apr 17, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.5258 (May 22, 2024) to a high of $0.6277 (May 15, 2024), with a median of $0.5258 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 56% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 70756061825) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.